Treatment of Splenic Marginal Zone B-Cell Lymphoma: An Analysis of 81 Patients
Authors:
- Pascale FelmanPFPascale Felman
- Françoise BergerFBFrançoise Berger
- Charles DumontetCDCharles Dumontet
- Philippe ArnaudPAPhilippe Arnaud
- Olivier HequetOHOlivier Hequet
- Josette ArcacheJAJosette Arcache
- Evelyne Callet-BauchuECEvelyne Callet-Bauchu
- Gilles SallesGSGilles Salles
- Bertrand CoiffierBCBertrand Coiffier
- 1 June 2002
- journal article
- research article
- Published by Elsevier in Clinical Lymphoma
- Vol. 3 (1) , 41-47
Abstract
No abstract availableKeywords
This publication has 15 references indexed in Scilit:
- Fludarabine: an effective treatment in patients with splenic lymphoma with villous lymphocytesLeukemia, 2000
- Non-MALT marginal zone B-cell lymphomas: a description of clinical presentation and outcome in 124 patientsBlood, 2000
- Fludarabine is effective in the treatment of splenic lymphoma with villous lymphocytesBritish Journal of Haematology, 1997
- Splenic lymphoma with villous lymphocytes: clinical presentation, biology and prognostic factors in a series of 100 patientsBritish Journal of Haematology, 1996
- Fourteen years of high-dose CHOP (ACVB regimen): Preliminary conclusions about the treatment of aggressive-lymphoma patientsAnnals of Oncology, 1995
- A revised European-American classification of lymphoid neoplasms: a proposal from the International Lymphoma Study Group [see comments]Blood, 1994
- Non-hodgkin's lymphoma.A study of the evolution of the disease based upon 92 autopsied casesCancer, 1979
- Design and analysis of randomized clinical trials requiring prolonged observation of each patient. II. Analysis and examplesBritish Journal of Cancer, 1977
- Staging laparotomies in unselected previously untreated patients with non-Hodgkin's lymphomasCancer, 1973
- Nonparametric Estimation from Incomplete ObservationsJournal of the American Statistical Association, 1958